Emerging pathways can help cell and gene therapies become commercially viable for intractable diseases, even with uneven scalability and consistency.

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

Dr Romain Joubert of AviadoBio explained how the company has used an adeno-associated virus gene replacement programme in ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

A 7-year-old girl can hear her mom's voice again, thanks to a radical gene therapy. Scientists just proved hereditary ...

The preference of mosquitoes for human blood has increased in recent years, resulting in more frequent human-mosquito interactions.

UF scientist develops safer gene therapy restoring vision in children with rare inherited eye diseases; pivotal trials begin ...

Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...

As gene therapies advance toward indications with larger patient populations, adeno-associated virus (AAV) manufacturers are under growing pressure to deliver high-quality vectors at substantially ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, tod ...

The protection of confidential communications, a strategic pillar in the information age, has just received a revolutionary ...